High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma

Br J Haematol. 2022 Mar;196(6):e67-e70. doi: 10.1111/bjh.17980. Epub 2021 Dec 27.

Authors

Affiliations

¹ Department of Hematology, Amsterdam UMC, Amsterdam, the Netherlands.
² Department or Blood Cell Research, Sanquin Research, Amsterdam, the Netherlands.

PMID: 34961917
DOI: 10.1111/bjh.17980

No abstract available

Keywords: autologous; consolidation; high-dose melphalan; multiple myeloma; stem cell transplantation.

Publication types

Letter

MeSH terms

Consolidation Chemotherapy
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Melphalan / therapeutic use
Multiple Myeloma* / drug therapy
Multiple Myeloma* / etiology
Stem Cell Transplantation / adverse effects
Transplantation Conditioning
Transplantation, Autologous

Substances

Melphalan